Thank you for subscribing!
Learn More about Next Investors - Experts in Biotech Stocks
Next Investors Feb 28, 2022
Our 2021 Biotech Pick of the Year Dimerix (ASX:DXB) released its half year report last Thursday, updating investors on ethics approvals for its Phase III clinical trial for FSGS (a rare kidney disease) and closing in on important milestones for TWO of its Phase III COVID-19 studies.
Next Investors Feb 18, 2022
Today we are finally announcing a new investment in the Next Investors portfolio. Arovella Therapeutics (ASX:ALA) is a small ASX biotech going after a unique solution to the scourge of cancer - with cutting edge technology licensed from some of the foremost cancer research institutions - and has attracted big names to the project.
Next Investors Feb 01, 2022
Dimerix (ASX:DXB) just delivered significant progress on its Phase III Clinical Trial for FSGS, with the first EU regulatory approval given for DXB’s kidney disease study in Denmark... earlier than expected.
Next Investors Oct 25, 2021
Today Creso Pharma’s (ASX:CPH) announced the acquisition of a range of CBD brand and product assets that deliver anti-inflammatory relief to professional and amateur athletes suffering from chronic muscle and joint pain.
Get expert stock analysis direct in your inbox
Next Investors Sep 27, 2021
On Friday last week, DXB announced that the main drug regulator in India has recommended approval for DXB’s Phase III clinical trials on COVID-19 treatment, specifically for patients with respiratory complications intended for hospitalisation — its CLARITY 2.0 study.
Next Investors Aug 17, 2021
CPH yesterday went on to announce the successful grant of a rare “Controlled Drugs and Substances license” licence for Haluenex in Canada, another positive step in their psychedelics story.
Next Investors Aug 16, 2021
Today we announce the fourth addition to our portfolio for 2021. Today we are adding Dimerix (ASX:DXB) to the Next Investors portfolio as our inaugural Biotech Pick of the Year for 2021.
Next Investors Archived Aug 01, 2021
eSense-Lab Ltd (ASX: ESE) has signed a research agreement with the Israeli Ministry of Health to commence a research project at the Central Virology lab in the Chaim Sheba Medical Centre — the largest hospital in Israel — to test its proprietary TRP-ENV™ compounds for a coronaviruses.
Next Investors Jul 01, 2021
Creso Pharma Ltd (ASX:CPH | OTC:COPHF) has just confirmed two consecutive quarters of record revenue growth. CPH posted $1.71M revenue this quarter - up from $1.38M in the previous quarter - that’s 24% growth.
Join Our Mailing List
